These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 8069582)

  • 1. Development of a novel drug release system, time-controlled explosion system (TES). I. Concept and design.
    Ueda S; Hata T; Asakura S; Yamaguchi H; Kotani M; Ueda Y
    J Drug Target; 1994; 2(1):35-44. PubMed ID: 8069582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a novel drug delivery system, time-controlled explosion system (TES). IV. In vivo drug release behavior.
    Ueda S; Ibuki R; Kawamura A; Murata S; Takahashi T; Kimura S; Hata T
    J Drug Target; 1994; 2(2):133-40. PubMed ID: 8069590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eudragit E as coating material for the pH-controlled drug release in the topical treatment of inflammatory bowel disease (IBD).
    Leopold CS; Eikeler D
    J Drug Target; 1998; 6(2):85-94. PubMed ID: 9886233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of novel sustained-release system, disintegration-controlled matrix tablet (DCMT) with solid dispersion granules of nilvadipine.
    Tanaka N; Imai K; Okimoto K; Ueda S; Tokunaga Y; Ohike A; Ibuki R; Higaki K; Kimura T
    J Control Release; 2005 Nov; 108(2-3):386-95. PubMed ID: 16253377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of an oral sustained release drug delivery system utilizing pH-dependent swelling of carboxyvinyl polymer.
    Nakamura K; Nara E; Akiyama Y
    J Control Release; 2006 Apr; 111(3):309-15. PubMed ID: 16473430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time and pH dependent colon specific, pulsatile delivery of theophylline for nocturnal asthma.
    Mastiholimath VS; Dandagi PM; Jain SS; Gadad AP; Kulkarni AR
    Int J Pharm; 2007 Jan; 328(1):49-56. PubMed ID: 16942847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a single unit extended release formulation for ZK 811 752, a weakly basic drug.
    Kranz H; Guthmann C; Wagner T; Lipp R; Reinhard J
    Eur J Pharm Sci; 2005 Sep; 26(1):47-53. PubMed ID: 15953712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of controlled-release SK&F 82526-J buffer bead formulations with tartaric acid as the buffer.
    Venkatesh GM
    Pharm Dev Technol; 1998 Nov; 3(4):477-85. PubMed ID: 9834950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of time-, pH-, and enzyme-controlled colonic drug delivery using spray-dried chitosan acetate and hydroxypropyl methylcellulose.
    Nunthanid J; Huanbutta K; Luangtana-Anan M; Sriamornsak P; Limmatvapirat S; Puttipipatkhachorn S
    Eur J Pharm Biopharm; 2008 Feb; 68(2):253-9. PubMed ID: 17616377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel pH-dependent gradient-release delivery system for nitrendipine II. Investigations of the factors affecting the release behaviors of the system.
    Yang M; Cui F; You B; Wang L; Yue P; Kawashima Y
    Int J Pharm; 2004 Nov; 286(1-2):99-109. PubMed ID: 15501006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanistic model for drug release during the lag phase from pellets coated with a semi-permeable membrane.
    Marucci M; Ragnarsson G; Nyman U; Axelsson A
    J Control Release; 2008 Apr; 127(1):31-40. PubMed ID: 18262303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel ethylcellulose-coated pellets for controlled release of metoprolol succinate without lag phase: characterization, optimization and in vivo evaluation.
    Wang Y; Yang J; Qian Y; Yang M; Qiu Y; Huang W; Shan L; Gao C
    Drug Dev Ind Pharm; 2015; 41(7):1120-9. PubMed ID: 24980911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of guar gum in the preparation of sustained-release matrix tablets.
    Khullar P; Khar RK; Agarwal SP
    Drug Dev Ind Pharm; 1998 Nov; 24(11):1095-9. PubMed ID: 9876566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulsatile multiparticulate drug delivery system for metoprolol succinate.
    Jagdale SC; Chede SM; Gulwady R; Kuchekar BS; Lokhande PD; Shah TP; Chabukswar AR
    Arch Pharm Res; 2011 Mar; 34(3):369-76. PubMed ID: 21547667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Swelling and binding effects in a polymeric microfiber model for controlled drug release.
    Alhaique F; Riccieri FM; Santucci E; Marchetti M
    Farmaco Sci; 1983 May; 38(5):309-17. PubMed ID: 6862001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formulation, release characteristics and bioavailability of novel monolithic hydroxypropylmethylcellulose matrix tablets containing acetaminophen.
    Cao QR; Choi YW; Cui JH; Lee BJ
    J Control Release; 2005 Nov; 108(2-3):351-61. PubMed ID: 16154656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. pH-sensitive polymer blends used as coating materials to control drug release from spherical beads: importance of the type of core.
    Lecomte F; Siepmann J; Walther M; Macrae RJ; Bodmeier R
    Biomacromolecules; 2005; 6(4):2074-83. PubMed ID: 16004447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlled delivery achieved with bi-layer matrix devices produced by co-injection moulding.
    Vaz CM; van Doeveren PF; Dias GR; Reis RL; Cunha AM
    Macromol Biosci; 2004 Aug; 4(8):795-801. PubMed ID: 15468273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral controlled release optimization of pellets prepared by extrusion-spheronization processing.
    Bianchini R; Vecchio C
    Farmaco; 1989 Jun; 44(6):645-54. PubMed ID: 2803450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of micronized cellulose disintegrants as insoluble swellable matrices for sustained-release tablets.
    Nakagami H; Nada M
    Drug Des Deliv; 1991 Jul; 7(4):321-32. PubMed ID: 1930623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.